Trial · NCT04562987
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | intervention attendance | 1 month post-chemotherapy | completion of telecoaching sessions |
| Primary | Participant satisfaction: survey | 1 month post-chemotherapy | usability survey |
| Primary | recruitment yield | Baseline | number of women who enroll compared to the number of contacts of eligible women required to obtain target sample size |
| Primary | retention | 1 month post-chemotherapy | proportion of participants providing post-intervention data |
| Primary | acceptability of intervention: in-depth interview | 1 month post-chemotherapy | in-depth interview to gather participant perceptions on the acceptability and usefulness of the mobile app features |
| Secondary | Change in Stroop task performance | Baseline, 1 month post-chemotherapy | Interference score on Stroop task |
| Secondary | Change in Task-Switch task performance | Baseline, 1 month post-chemotherapy | Reaction time on Task-Switch |
| Secondary | Change in Trails task performance | Baseline, 1 month post-chemotherapy | Completion time of Trails |
| Secondary | Change in N-Back task performance | Baseline, 1 month post-chemotherapy | Correct responses on N-back |
| Secondary | Change in Spatial Working Memory task performance | Baseline, 1 month post-chemotherapy | Correct responses on Spatial Working Memory task |
| Secondary | Change in Auditory Verbal Learning Task (AVLT) performance | Baseline, 1 month post-chemotherapy | Total numbered recalled on AVLT |
| Secondary | Change in objective physical activity behavior | Baseline, 1 month post-chemotherapy | Objective activity behavior (average minutes of physical activity per day) will be measured using actigraphy. |
| Other | Change in cancer-related Fatigue | Baseline, 1 month post-chemotherapy | The Functional Assessment in Chronic Illness Therapy (FACIT) - Fatigue Scale will be used to measure cancer-related fatigue. Scores range from 0-52, with higher scores indicating less cancer-related fatigue. |
| Other | Momentary symptoms | 14 days 4 times per day at each of the following time points: baseline, mid-intervention (2-3 months from baseline), 1 month post-chemotherapy | A brief ecological momentary assessment prompted to participants' smartphones will be used to measure momentary symptoms, including anxiety, stress, fatigue, focus, pain, and nausea. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04562987/registered